IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells

Leukemia

Volumn 12, Issue 5, 1998, Pages 682-689

  Antoku, K ^a   Liu, Z ^a   Johnson, D E ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Apoptosis; Caspase; IL 3; Myeloid; PARP

Indexed keywords

BCR ABL PROTEIN; CYTOKINE; FAS ANTIGEN; INTERLEUKIN 3; KETONE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; COWPOX VIRUS; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROTO ONCOGENE;

EID: 0031919884     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400992     Document Type: Article

References (16)

1. Metcalf D. The molecular control of blood forming cells. Nature 1989; 339: 27-30.
2. Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Ann Rev Biochem 1990; 59: 783-836.
3. Metcalf D. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science 1991; 254: 529-533.
4. Williams G, Smith C, Spooncer E, Dexter T, Taylor D. Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76-79.
5. Rodriquez-Tarduchy G, Collins M, Lopez-Rivas A. Regulation of apoptosis in interleukin-3-depndent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 1990; 9: 2997-3002.
6. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
7. Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Ann Rev Cell Biol 1991; 7: 663-698.
8. L. Cell 1996; 87: 619-628.
9. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1998; 335: 440-442.
10. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-dependent hemopoietic cell lines. J Immunol 1990; 144: 3602-3610.
11. May WS, Tyler PC, Ito T, Armstrong DK, Qatsha KA, Davison NE. lnterleukin-3 and bryostatin-1 mediate hyperphosphorylation of Bcl2α in association with suppression of apoptosis. J Biol Chem 1994; 269: 26865-26870.
12. Gottlieb E, Haffner R, von Ruden T, Wagner EF, Oren M. Downregulation of wild-type p53 activity interferes with apoptosis of IL3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J 1994; 13: 1368-1374.
13. Blandino G, Scardigli R, Rizzo MG, Crescenzi M, Soddu S, Sacchi A. Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells. Oncogene 1995; 10: 731-737.
14. Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 1995; 9: 600-611.
15. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995; 82: 349-352.
16. Fraser A, Evan G. A license to kill. Cell 1996; 85: 781-784.